Tuesday, November 07, 2017 10:34:27 AM
As for Q1 and Q2 this is news to me and should have been conveyed at the time of acquisition. We all fear dilution and here we see that no major capital investment was made. This is excellent.
Q4 - OK not a big thing on my list. EVIO already got paid and we won't be bringing in massive revenue from the FL license agreement.
Q5 - about time we hear something from Mass. That lab was not cheap. Is regulated testing as big as in OR? Seems like Mass has the same revenue potential as OR.
Lacking.... What's the CO 'license agreement' all about?
Hey maybe the pref Ds are all cashed out by now?
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM